<DOC>
	<DOC>NCT00746304</DOC>
	<brief_summary>To investigate long-term treatment outcomes of patients receiving botulinum toxin A therapy for infantile and acquired esotropia.</brief_summary>
	<brief_title>Long-Term Outcomes in the Treatment of Infantile and Acquired Esotropia With Botulinum Toxin</brief_title>
	<detailed_description>Participants: 164 patients with infantile esotropia and 89 patients with acquired esotropia. Methods: Patients were injected with botulinum toxin into two medial rectus muscles and followed from 1992 to 2005. Patients were evaluated at 1 week, 2, 6 and 12 months, and then yearly post-injection. Main Outcome Measures: Degree of motor alignment, recurrence rate, incidence of stereopsis, and dissociated vertical deviation along with complications.</detailed_description>
	<mesh_term>Esotropia</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>infantile esotropia and acquired esotropia exotropia, high AC/A ratio accommodative esotropia, patients with neurological deficit including cerebral palsy, Down syndrome and mental retardation, and ocular anomalies including retinopathy of prematurity. Patients lost to followup at 6 months or less after the last injection were also excluded.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>botulinum</keyword>
	<keyword>esotropia</keyword>
</DOC>